Randal J. Kirk serves as Executive at NEW RIVER PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Randal J. Kirk has executed 895 insider transactions totaling $687.4M, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 11, 2017 involved purchasing 132,625 shares valued at $2.5M.
Randal J. Kirk currently holds 81,609,648 shares of NEW RIVER PHARMACEUTICALS INC (NRPH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Randal J. Kirk has been a net buyer of NRPH stock. They have purchased $545.9M and sold $141.5M worth of shares.
Randal J. Kirk's most recent insider trade was on Aug 11, 2017, when they purchased 132,625 shares at $18.85 per share.
Get notified when new Form 4 filings are submitted
| $21.59 |
| Discretionary |
| Jul 31, 2017 | XON | $800.0K | Award | 34,587 | $23.13 | Discretionary |
| Jul 24, 2017 | XON | $0 | Other | 8,099,238 | $N/A | Discretionary |
| Jul 24, 2017 | XON | $0 | Other | 8,325,000 | $N/A | Discretionary |
| Jul 24, 2017 | XON | $0 | Other | 22,636,052 | $N/A | Discretionary |
| Jul 24, 2017 | HALO | $0 | Other | 2,327,603 | $N/A | Discretionary |
| Jul 24, 2017 | HALO | $0 | Other | 6,328,853 | $N/A | Discretionary |
| Jul 24, 2017 | HALO | $0 | Other | 2,264,483 | $N/A | Discretionary |
| Jul 24, 2017 | AQB | $0 | Other | 338,816 | $N/A | Discretionary |
| Jul 24, 2017 | AQB | $0 | Other | 124,609 | $N/A | Discretionary |
| Jul 24, 2017 | AQB | $0 | Other | 121,231 | $N/A | Discretionary |
| Jun 30, 2017 | XON | $200.0K | Award | 8,302 | $24.09 | Discretionary |
| Jun 30, 2017 | XON | $800.0K | Award | 35,056 | $22.82 | Discretionary |
| Jun 29, 2017 | TBIO | $0 | Conversion | 1,431 | $N/A | Discretionary |
| Jun 29, 2017 | TBIO | $2.1M | Conversion | 141,052 | $15.00 | Discretionary |
| Jun 29, 2017 | TBIO | $0 | Conversion | 1,431 | $N/A | Discretionary |
| Jun 29, 2017 | TBIO | $0 | Conversion | 1,431 | $N/A | Discretionary |
| Jun 29, 2017 | TBIO | $1.1M | Conversion | 70,526 | $15.00 | Discretionary |
| Jun 29, 2017 | TBIO | $2.1M | Conversion | 141,052 | $15.00 | Discretionary |
| Jun 29, 2017 | TBIO | $0 | Conversion | 2,862 | $N/A | Discretionary |
| Jun 8, 2017 | TBIO | $395.0K | Sale | 395,000 | $1.00 | Discretionary |
| Jun 8, 2017 | TBIO | $682.0K | Sale | 682,000 | $1.00 | Discretionary |
| Jun 8, 2017 | TBIO | $108.0K | Sale | 108,000 | $1.00 | Discretionary |
| Jun 8, 2017 | TBIO | $790.0K | Sale | 790,000 | $1.00 | Discretionary |
| May 31, 2017 | XON | $200.0K | Award | 9,380 | $21.32 | Discretionary |
| May 31, 2017 | XON | $800.0K | Award | 31,164 | $25.67 | Discretionary |
| May 11, 2017 | HALO | $103.7K | Option Exercise | 10,000 | $10.37 | Discretionary |
| May 8, 2017 | SNGX | $4.8K | Sale | 1,881 | $2.54 | Discretionary |
| May 8, 2017 | SNGX | $24.6K | Sale | 9,695 | $2.54 | Discretionary |